These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 12870114

  • 1. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae.
    Briles DE, Hollingshead SK, Paton JC, Ades EW, Novak L, van Ginkel FW, Benjamin WH.
    J Infect Dis; 2003 Aug 01; 188(3):339-48. PubMed ID: 12870114
    [Abstract] [Full Text] [Related]

  • 2. Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung.
    Arévalo MT, Xu Q, Paton JC, Hollingshead SK, Pichichero ME, Briles DE, Girgis N, Zeng M.
    FEMS Immunol Med Microbiol; 2009 Apr 01; 55(3):346-51. PubMed ID: 19291171
    [Abstract] [Full Text] [Related]

  • 3. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA.
    Briles DE, Hollingshead SK, King J, Swift A, Braun PA, Park MK, Ferguson LM, Nahm MH, Nabors GS.
    J Infect Dis; 2000 Dec 01; 182(6):1694-701. PubMed ID: 11069242
    [Abstract] [Full Text] [Related]

  • 4. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
    Hanniffy SB, Carter AT, Hitchin E, Wells JM.
    J Infect Dis; 2007 Jan 15; 195(2):185-93. PubMed ID: 17191163
    [Abstract] [Full Text] [Related]

  • 5. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT, Kim SY, Kim MS, Lee SE, Rhee JH.
    Vaccine; 2011 Aug 05; 29(34):5731-9. PubMed ID: 21696869
    [Abstract] [Full Text] [Related]

  • 6. Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized and can protect splenectomized mice from infection with Streptococcus pneumoniae.
    Coats MT, Benjamin WH, Hollingshead SK, Briles DE.
    Vaccine; 2005 Jul 21; 23(33):4257-62. PubMed ID: 16005736
    [Abstract] [Full Text] [Related]

  • 7. Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.
    Chen A, Mann B, Gao G, Heath R, King J, Maissoneuve J, Alderson M, Tate A, Hollingshead SK, Tweten RK, Briles DE, Tuomanen EI, Paton JC.
    Clin Vaccine Immunol; 2015 Oct 21; 22(10):1079-89. PubMed ID: 26245351
    [Abstract] [Full Text] [Related]

  • 8. DNA vaccines based on genetically detoxified derivatives of pneumolysin fail to protect mice against challenge with Streptococcus pneumoniae.
    Ferreira DM, Arêas AP, Darrieux M, Leite LC, Miyaji EN.
    FEMS Immunol Med Microbiol; 2006 Mar 21; 46(2):291-7. PubMed ID: 16487311
    [Abstract] [Full Text] [Related]

  • 9. Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.
    Moore QC, Bosarge JR, Quin LR, McDaniel LS.
    Vaccine; 2006 Jul 17; 24(29-30):5755-61. PubMed ID: 16759765
    [Abstract] [Full Text] [Related]

  • 10. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
    Cao J, Chen D, Xu W, Chen T, Xu S, Luo J, Zhao Q, Liu B, Wang D, Zhang X, Shan Y, Yin Y.
    Vaccine; 2007 Jun 28; 25(27):4996-5005. PubMed ID: 17524530
    [Abstract] [Full Text] [Related]

  • 11. Intranasal vaccination with pneumococcal surface protein A plus poly(I:C) protects against secondary pneumococcal pneumonia in mice.
    Ezoe H, Akeda Y, Piao Z, Aoshi T, Koyama S, Tanimoto T, Ishii KJ, Oishi K.
    Vaccine; 2011 Feb 17; 29(9):1754-61. PubMed ID: 21219977
    [Abstract] [Full Text] [Related]

  • 12. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C, Lin H, Huang J, Wang H, Cai Q, Fang L, Guo Y.
    Microb Pathog; 2009 Sep 17; 47(3):151-6. PubMed ID: 19467319
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
    Li B, Chen X, Yu J, Zhang Y, Mo Z, Gu T, Kong W, Wu Y.
    Microb Pathog; 2018 Oct 17; 123():115-119. PubMed ID: 29959043
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Protection of the elderly from pneumococcal pneumonia with a protein-based vaccine?
    Briles DE.
    Mech Ageing Dev; 2004 Feb 17; 125(2):129-31. PubMed ID: 15037017
    [Abstract] [Full Text] [Related]

  • 17. A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae.
    Denoël P, Philipp MT, Doyle L, Martin D, Carletti G, Poolman JT.
    Vaccine; 2011 Jul 26; 29(33):5495-501. PubMed ID: 21624422
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin.
    García-Suárez Mdel M, Cima-Cabal MD, Flórez N, García P, Cernuda-Cernuda R, Astudillo A, Vázquez F, De los Toyos JR, Méndez FJ.
    Infect Immun; 2004 Aug 26; 72(8):4534-40. PubMed ID: 15271913
    [Abstract] [Full Text] [Related]

  • 20. Effective protection against secondary pneumococcal pneumonia by oral vaccination with attenuated Salmonella delivering PspA antigen in mice.
    Seo SU, Kim JJ, Yang H, Kwon HJ, Yang JY, Curtiss Iii R, Kweon MN.
    Vaccine; 2012 Nov 06; 30(48):6816-23. PubMed ID: 23000127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.